Cancer Biopsy Market, Global Outlook and Forecast 2022-2028

January 2022 | 107 pages | ID: C71D3ABCFC22EN
Market Monitor Global

Abstracts

For most types of cancer, biopsy is the main way doctors diagnose cancer. A biopsy is a microscopic examination of a small amount of tissue. Other tests may indicate that cancer exists, but only biopsy can make a definite diagnosis.

This report contains market size and forecasts of Cancer Biopsy in Global, including the following market information:

Global Cancer Biopsy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cancer Biopsy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tissue Biopsies Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cancer Biopsy include Qiagen N.V., Illumina, Inc., ANGLE Plc, Myriad Genetics, Hologic, Inc., Biocept, Inc., Thermo Fisher Scientific, Inc., Danaher and Lucence Diagnostics Pte. Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cancer Biopsy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cancer Biopsy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cancer Biopsy Market Segment Percentages, by Type, 2021 (%)

• Tissue Biopsies
• Liquid Biopsies
• Others

Global Cancer Biopsy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cancer Biopsy Market Segment Percentages, by Application, 2021 (%)

• Breast Cancer
• Colorectal Cancer
• Cervical Cancers
• Lung Cancers
• Prostate Cancers
• Skin Cancers
• Blood Cancers
• Kidney Cancers
• Others

Global Cancer Biopsy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cancer Biopsy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cancer Biopsy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cancer Biopsy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Qiagen N.V.
• Illumina, Inc.
• ANGLE Plc
• Myriad Genetics
• Hologic, Inc.
• Biocept, Inc.
• Thermo Fisher Scientific, Inc.
• Danaher
• Lucence Diagnostics Pte. Ltd.
• GRAIL, Inc.
• Guardant Health
• Exact Sciences Corporation
• Freenome Holdings, Inc.
• Oncimmune
• Chronix Biomedical, Inc.
• Personal Genome Diagnostics Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Cancer Biopsy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Cancer Biopsy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CANCER BIOPSY OVERALL MARKET SIZE

2.1 Global Cancer Biopsy Market Size: 2021 VS 2028
2.2 Global Cancer Biopsy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Cancer Biopsy Players in Global Market
3.2 Top Global Cancer Biopsy Companies Ranked by Revenue
3.3 Global Cancer Biopsy Revenue by Companies
3.4 Top 3 and Top 5 Cancer Biopsy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer Biopsy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Biopsy Players in Global Market
  3.6.1 List of Global Tier 1 Cancer Biopsy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Cancer Biopsy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Cancer Biopsy Market Size Markets, 2021 & 2028
  4.1.2 Tissue Biopsies
  4.1.3 Liquid Biopsies
  4.1.4 Others
4.2 By Type - Global Cancer Biopsy Revenue & Forecasts
  4.2.1 By Type - Global Cancer Biopsy Revenue, 2017-2022
  4.2.2 By Type - Global Cancer Biopsy Revenue, 2023-2028
  4.2.3 By Type - Global Cancer Biopsy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Cancer Biopsy Market Size, 2021 & 2028
  5.1.2 Breast Cancer
  5.1.3 Colorectal Cancer
  5.1.4 Cervical Cancers
  5.1.5 Lung Cancers
  5.1.6 Prostate Cancers
  5.1.7 Skin Cancers
  5.1.8 Blood Cancers
  5.1.9 Kidney Cancers
  5.1.10 Others
5.2 By Application - Global Cancer Biopsy Revenue & Forecasts
  5.2.1 By Application - Global Cancer Biopsy Revenue, 2017-2022
  5.2.2 By Application - Global Cancer Biopsy Revenue, 2023-2028
  5.2.3 By Application - Global Cancer Biopsy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Cancer Biopsy Market Size, 2021 & 2028
6.2 By Region - Global Cancer Biopsy Revenue & Forecasts
  6.2.1 By Region - Global Cancer Biopsy Revenue, 2017-2022
  6.2.2 By Region - Global Cancer Biopsy Revenue, 2023-2028
  6.2.3 By Region - Global Cancer Biopsy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Cancer Biopsy Revenue, 2017-2028
  6.3.2 US Cancer Biopsy Market Size, 2017-2028
  6.3.3 Canada Cancer Biopsy Market Size, 2017-2028
  6.3.4 Mexico Cancer Biopsy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Cancer Biopsy Revenue, 2017-2028
  6.4.2 Germany Cancer Biopsy Market Size, 2017-2028
  6.4.3 France Cancer Biopsy Market Size, 2017-2028
  6.4.4 U.K. Cancer Biopsy Market Size, 2017-2028
  6.4.5 Italy Cancer Biopsy Market Size, 2017-2028
  6.4.6 Russia Cancer Biopsy Market Size, 2017-2028
  6.4.7 Nordic Countries Cancer Biopsy Market Size, 2017-2028
  6.4.8 Benelux Cancer Biopsy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Cancer Biopsy Revenue, 2017-2028
  6.5.2 China Cancer Biopsy Market Size, 2017-2028
  6.5.3 Japan Cancer Biopsy Market Size, 2017-2028
  6.5.4 South Korea Cancer Biopsy Market Size, 2017-2028
  6.5.5 Southeast Asia Cancer Biopsy Market Size, 2017-2028
  6.5.6 India Cancer Biopsy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Cancer Biopsy Revenue, 2017-2028
  6.6.2 Brazil Cancer Biopsy Market Size, 2017-2028
  6.6.3 Argentina Cancer Biopsy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Cancer Biopsy Revenue, 2017-2028
  6.7.2 Turkey Cancer Biopsy Market Size, 2017-2028
  6.7.3 Israel Cancer Biopsy Market Size, 2017-2028
  6.7.4 Saudi Arabia Cancer Biopsy Market Size, 2017-2028
  6.7.5 UAE Cancer Biopsy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Qiagen N.V.
  7.1.1 Qiagen N.V. Corporate Summary
  7.1.2 Qiagen N.V. Business Overview
  7.1.3 Qiagen N.V. Cancer Biopsy Major Product Offerings
  7.1.4 Qiagen N.V. Cancer Biopsy Revenue in Global Market (2017-2022)
  7.1.5 Qiagen N.V. Key News
7.2 Illumina, Inc.
  7.2.1 Illumina, Inc. Corporate Summary
  7.2.2 Illumina, Inc. Business Overview
  7.2.3 Illumina, Inc. Cancer Biopsy Major Product Offerings
  7.2.4 Illumina, Inc. Cancer Biopsy Revenue in Global Market (2017-2022)
  7.2.5 Illumina, Inc. Key News
7.3 ANGLE Plc
  7.3.1 ANGLE Plc Corporate Summary
  7.3.2 ANGLE Plc Business Overview
  7.3.3 ANGLE Plc Cancer Biopsy Major Product Offerings
  7.3.4 ANGLE Plc Cancer Biopsy Revenue in Global Market (2017-2022)
  7.3.5 ANGLE Plc Key News
7.4 Myriad Genetics
  7.4.1 Myriad Genetics Corporate Summary
  7.4.2 Myriad Genetics Business Overview
  7.4.3 Myriad Genetics Cancer Biopsy Major Product Offerings
  7.4.4 Myriad Genetics Cancer Biopsy Revenue in Global Market (2017-2022)
  7.4.5 Myriad Genetics Key News
7.5 Hologic, Inc.
  7.5.1 Hologic, Inc. Corporate Summary
  7.5.2 Hologic, Inc. Business Overview
  7.5.3 Hologic, Inc. Cancer Biopsy Major Product Offerings
  7.5.4 Hologic, Inc. Cancer Biopsy Revenue in Global Market (2017-2022)
  7.5.5 Hologic, Inc. Key News
7.6 Biocept, Inc.
  7.6.1 Biocept, Inc. Corporate Summary
  7.6.2 Biocept, Inc. Business Overview
  7.6.3 Biocept, Inc. Cancer Biopsy Major Product Offerings
  7.6.4 Biocept, Inc. Cancer Biopsy Revenue in Global Market (2017-2022)
  7.6.5 Biocept, Inc. Key News
7.7 Thermo Fisher Scientific, Inc.
  7.7.1 Thermo Fisher Scientific, Inc. Corporate Summary
  7.7.2 Thermo Fisher Scientific, Inc. Business Overview
  7.7.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Major Product Offerings
  7.7.4 Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue in Global Market (2017-2022)
  7.7.5 Thermo Fisher Scientific, Inc. Key News
7.8 Danaher
  7.8.1 Danaher Corporate Summary
  7.8.2 Danaher Business Overview
  7.8.3 Danaher Cancer Biopsy Major Product Offerings
  7.8.4 Danaher Cancer Biopsy Revenue in Global Market (2017-2022)
  7.8.5 Danaher Key News
7.9 Lucence Diagnostics Pte. Ltd.
  7.9.1 Lucence Diagnostics Pte. Ltd. Corporate Summary
  7.9.2 Lucence Diagnostics Pte. Ltd. Business Overview
  7.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Major Product Offerings
  7.9.4 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue in Global Market (2017-2022)
  7.9.5 Lucence Diagnostics Pte. Ltd. Key News
7.10 GRAIL, Inc.
  7.10.1 GRAIL, Inc. Corporate Summary
  7.10.2 GRAIL, Inc. Business Overview
  7.10.3 GRAIL, Inc. Cancer Biopsy Major Product Offerings
  7.10.4 GRAIL, Inc. Cancer Biopsy Revenue in Global Market (2017-2022)
  7.10.5 GRAIL, Inc. Key News
7.11 Guardant Health
  7.11.1 Guardant Health Corporate Summary
  7.11.2 Guardant Health Business Overview
  7.11.3 Guardant Health Cancer Biopsy Major Product Offerings
  7.11.4 Guardant Health Cancer Biopsy Revenue in Global Market (2017-2022)
  7.11.5 Guardant Health Key News
7.12 Exact Sciences Corporation
  7.12.1 Exact Sciences Corporation Corporate Summary
  7.12.2 Exact Sciences Corporation Business Overview
  7.12.3 Exact Sciences Corporation Cancer Biopsy Major Product Offerings
  7.12.4 Exact Sciences Corporation Cancer Biopsy Revenue in Global Market (2017-2022)
  7.12.5 Exact Sciences Corporation Key News
7.13 Freenome Holdings, Inc.
  7.13.1 Freenome Holdings, Inc. Corporate Summary
  7.13.2 Freenome Holdings, Inc. Business Overview
  7.13.3 Freenome Holdings, Inc. Cancer Biopsy Major Product Offerings
  7.13.4 Freenome Holdings, Inc. Cancer Biopsy Revenue in Global Market (2017-2022)
  7.13.5 Freenome Holdings, Inc. Key News
7.14 Oncimmune
  7.14.1 Oncimmune Corporate Summary
  7.14.2 Oncimmune Business Overview
  7.14.3 Oncimmune Cancer Biopsy Major Product Offerings
  7.14.4 Oncimmune Cancer Biopsy Revenue in Global Market (2017-2022)
  7.14.5 Oncimmune Key News
7.15 Chronix Biomedical, Inc.
  7.15.1 Chronix Biomedical, Inc. Corporate Summary
  7.15.2 Chronix Biomedical, Inc. Business Overview
  7.15.3 Chronix Biomedical, Inc. Cancer Biopsy Major Product Offerings
  7.15.4 Chronix Biomedical, Inc. Cancer Biopsy Revenue in Global Market (2017-2022)
  7.15.5 Chronix Biomedical, Inc. Key News
7.16 Personal Genome Diagnostics Inc.
  7.16.1 Personal Genome Diagnostics Inc. Corporate Summary
  7.16.2 Personal Genome Diagnostics Inc. Business Overview
  7.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Major Product Offerings
  7.16.4 Personal Genome Diagnostics Inc. Cancer Biopsy Revenue in Global Market (2017-2022)
  7.16.5 Personal Genome Diagnostics Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Cancer Biopsy Market Opportunities & Trends in Global Market
Table 2. Cancer Biopsy Market Drivers in Global Market
Table 3. Cancer Biopsy Market Restraints in Global Market
Table 4. Key Players of Cancer Biopsy in Global Market
Table 5. Top Cancer Biopsy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer Biopsy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer Biopsy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer Biopsy Product Type
Table 9. List of Global Tier 1 Cancer Biopsy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Biopsy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Cancer Biopsy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer Biopsy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer Biopsy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Cancer Biopsy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer Biopsy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer Biopsy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Cancer Biopsy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer Biopsy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer Biopsy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer Biopsy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer Biopsy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer Biopsy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer Biopsy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer Biopsy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer Biopsy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer Biopsy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer Biopsy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer Biopsy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer Biopsy Revenue, (US$, Mn), 2023-2028
Table 30. Qiagen N.V. Corporate Summary
Table 31. Qiagen N.V. Cancer Biopsy Product Offerings
Table 32. Qiagen N.V. Cancer Biopsy Revenue (US$, Mn), (2017-2022)
Table 33. Illumina, Inc. Corporate Summary
Table 34. Illumina, Inc. Cancer Biopsy Product Offerings
Table 35. Illumina, Inc. Cancer Biopsy Revenue (US$, Mn), (2017-2022)
Table 36. ANGLE Plc Corporate Summary
Table 37. ANGLE Plc Cancer Biopsy Product Offerings
Table 38. ANGLE Plc Cancer Biopsy Revenue (US$, Mn), (2017-2022)
Table 39. Myriad Genetics Corporate Summary
Table 40. Myriad Genetics Cancer Biopsy Product Offerings
Table 41. Myriad Genetics Cancer Biopsy Revenue (US$, Mn), (2017-2022)
Table 42. Hologic, Inc. Corporate Summary
Table 43. Hologic, Inc. Cancer Biopsy Product Offerings
Table 44. Hologic, Inc. Cancer Biopsy Revenue (US$, Mn), (2017-2022)
Table 45. Biocept, Inc. Corporate Summary
Table 46. Biocept, Inc. Cancer Biopsy Product Offerings
Table 47. Biocept, Inc. Cancer Biopsy Revenue (US$, Mn), (2017-2022)
Table 48. Thermo Fisher Scientific, Inc. Corporate Summary
Table 49. Thermo Fisher Scientific, Inc. Cancer Biopsy Product Offerings
Table 50. Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue (US$, Mn), (2017-2022)
Table 51. Danaher Corporate Summary
Table 52. Danaher Cancer Biopsy Product Offerings
Table 53. Danaher Cancer Biopsy Revenue (US$, Mn), (2017-2022)
Table 54. Lucence Diagnostics Pte. Ltd. Corporate Summary
Table 55. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product Offerings
Table 56. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue (US$, Mn), (2017-2022)
Table 57. GRAIL, Inc. Corporate Summary
Table 58. GRAIL, Inc. Cancer Biopsy Product Offerings
Table 59. GRAIL, Inc. Cancer Biopsy Revenue (US$, Mn), (2017-2022)
Table 60. Guardant Health Corporate Summary
Table 61. Guardant Health Cancer Biopsy Product Offerings
Table 62. Guardant Health Cancer Biopsy Revenue (US$, Mn), (2017-2022)
Table 63. Exact Sciences Corporation Corporate Summary
Table 64. Exact Sciences Corporation Cancer Biopsy Product Offerings
Table 65. Exact Sciences Corporation Cancer Biopsy Revenue (US$, Mn), (2017-2022)
Table 66. Freenome Holdings, Inc. Corporate Summary
Table 67. Freenome Holdings, Inc. Cancer Biopsy Product Offerings
Table 68. Freenome Holdings, Inc. Cancer Biopsy Revenue (US$, Mn), (2017-2022)
Table 69. Oncimmune Corporate Summary
Table 70. Oncimmune Cancer Biopsy Product Offerings
Table 71. Oncimmune Cancer Biopsy Revenue (US$, Mn), (2017-2022)
Table 72. Chronix Biomedical, Inc. Corporate Summary
Table 73. Chronix Biomedical, Inc. Cancer Biopsy Product Offerings
Table 74. Chronix Biomedical, Inc. Cancer Biopsy Revenue (US$, Mn), (2017-2022)
Table 75. Personal Genome Diagnostics Inc. Corporate Summary
Table 76. Personal Genome Diagnostics Inc. Cancer Biopsy Product Offerings
Table 77. Personal Genome Diagnostics Inc. Cancer Biopsy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Cancer Biopsy Segment by Type in 2021
Figure 2. Cancer Biopsy Segment by Application in 2021
Figure 3. Global Cancer Biopsy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cancer Biopsy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Biopsy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Biopsy Revenue in 2021
Figure 8. By Type - Global Cancer Biopsy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer Biopsy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer Biopsy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer Biopsy Revenue Market Share, 2017-2028
Figure 12. US Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer Biopsy Revenue Market Share, 2017-2028
Figure 16. Germany Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer Biopsy Revenue Market Share, 2017-2028
Figure 24. China Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer Biopsy Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer Biopsy Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer Biopsy Revenue, (US$, Mn), 2017-2028
Figure 37. Qiagen N.V. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Illumina, Inc. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. ANGLE Plc Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Myriad Genetics Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Hologic, Inc. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Biocept, Inc. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Thermo Fisher Scientific, Inc. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Danaher Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. GRAIL, Inc. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Guardant Health Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Exact Sciences Corporation Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Freenome Holdings, Inc. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Oncimmune Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Chronix Biomedical, Inc. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Personal Genome Diagnostics Inc. Cancer Biopsy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)